Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.05
+0.09 (0.82%)
Nov 21, 2024, 10:49 AM EST - Market open
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $268.40 million as of November 21, 2024.
Market Cap
268.40M
Enterprise Value
134.55M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $268.40M, an increase of 51.84%. That is a compound annual growth rate of 241.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 266.21M | 50.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AngioDynamics | 273.87M |
| Eton Pharmaceuticals | 269.47M |
| Ocugen | 267.58M |
| Atea Pharmaceuticals | 266.90M |
| Atai Life Sciences | 266.80M |
| Poseida Therapeutics | 265.10M |
| Fate Therapeutics | 252.85M |
| Anika Therapeutics | 251.61M |